Ascentage Pharma Group International American Depository Shares (AAPG) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Phibro Animal Health (PAHC) has outperformed Ascentage Pharma Group International American Depository Shares (AAPG) over the past year, gaining 3.0% versus a loss of 60.1%. Phibro Animal Health is the larger company by market cap ($1.56 billion vs $1.38 billion), about 1.1 times the size. Phibro Animal Health pays a dividend yielding 1.25%, while Ascentage Pharma Group International American Depository Shares does not currently pay one.
Phibro Animal Health converts more of its revenue into profit, with a net margin of 6.6% versus -41.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AAPG | PAHC |
|---|---|---|
| Share price | $14.75 | $38.30 |
| Market cap | $1.38B | $1.56B |
| 1-day change | +1.37% | +2.41% |
| YTD return | -43.79% | +2.52% |
| 1-year return | -60.15% | +3.04% |
| 5-year return | — | +75.69% |
| P/E ratio (TTM) | — | 15.76 |
| Forward P/E | — | 9.97 |
| EPS (TTM) | $-2.26 | $2.43 |
| Dividend yield | 0.00% | 1.25% |
| Annual dividend | $0.00 | $0.48 |
| Revenue (latest FY) | $134.35M | $1.52B |
| Revenue growth (YoY) | — | +17.12% |
| Net income (latest FY) | $-55.54M | $99.72M |
| Gross margin | 97.03% | 33.76% |
| Operating margin | — | 12.81% |
| Net margin | -41.34% | 6.57% |
| 52-week high | $37.50 | $60.08 |
| 52-week low | $14.46 | $28.25 |
| Distance from 52-week high | -60.67% | -36.25% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +219.53% | +14.88% |
| Average volume | 6.33K | 231.66K |
| Shares outstanding | 93.39M | 21.11M |
| Employees | 828 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PAHC has outperformed AAPG by 63.2 percentage points over the past year.
- Phibro Animal Health offers a meaningfully higher dividend yield (1.25% vs 0.00%).
- Phibro Animal Health is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -41.3 cents for Ascentage Pharma Group International American Depository Shares.
About Ascentage Pharma Group International American Depository Shares
AAPG stock →Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.
Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
AAPG vs PAHC FAQ
Which is bigger, Ascentage Pharma Group International American Depository Shares or Phibro Animal Health?
Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.56B compared with $1.38B for Ascentage Pharma Group International American Depository Shares (AAPG).
Which stock has performed better over the past year, AAPG or PAHC?
PAHC returned +3.04% over the past 12 months, compared with -60.15% for AAPG (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Ascentage Pharma Group International American Depository Shares or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.25%, while Ascentage Pharma Group International American Depository Shares does not currently pay a regular dividend.
Are Ascentage Pharma Group International American Depository Shares and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.